Data presented by medimmune at aap national conference & exhibition demonstrating burden of rsv disease
MedImmune has announced that it will present four abstracts at the American Academy of Pediatrics (AAP) 2008 National Conference & Exhibition that add to the company’s growing body of research into the prevention of respiratory syncytial virus (RSV), a leading cause of viral respiratory infection among preterm infants. “As we gain data that further demonstrate the burden of RSV disease on preterm babies, the benefits of preventive care become more evident,” said Jessie R. (Source: Asthma / Respiratory News From Medical News Today)
MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.
Tags:
Academy,
Medical,
National,
term
Related posts
Tags: Academy, Medical, National, term
This entry was posted
on wtorek, październik 14th, 2008 at 9:54 po południu and is filed under Medical Academies.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.
Data presented by medimmune at aap national conference & exhibition demonstrating burden of rsv disease
MedImmune has announced that it will present four abstracts at the American Academy of Pediatrics (AAP) 2008 National Conference & Exhibition that add to the company’s growing body of research into the prevention of respiratory syncytial virus (RSV), a leading cause of viral respiratory infection among preterm infants. “As we gain data that further demonstrate the burden of RSV disease on preterm babies, the benefits of preventive care become more evident,” said Jessie R. (Source: Asthma / Respiratory News From Medical News Today)
MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.
Tags:
Academy,
Medical,
National,
term
Related posts
Tags: Academy, Medical, National, term
This entry was posted
on wtorek, październik 14th, 2008 at 9:54 po południu and is filed under Medical Academies.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.